Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    -0.05 (-2.86%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Form 8.5 (EPT/RI)

26 May 2021 08:48

RNS Number : 8649Z
Citigroup Global Markets Limited
26 May 2021
 

 

 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Globalworth Real Estate Investments Limited

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Globalworth Real Estate Investments Limited

(d) Date dealing undertaken:

25 May 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received(EUR)

Lowest price per unit paid/received(EUR)

Ordinary

Purchase

101

7.1200

7.1200

Ordinary

Sale

101

7.1200

7.1200

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Type e.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

26 May 2021

Contact name:

Cathal McKenna

Telephone number:

02890 409 544

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERDZGZKNVNGMZG
Date   Source Headline
9th May 20187:00 amRNSAcquisition in Poland
30th Apr 20181:00 pmRNSNotice of AGM
27th Apr 20188:45 amRNSGlobalworth Poland AGM Result
24th Apr 20185:03 pmRNSPost Stabilisation Notice - Globalworth
17th Apr 20187:00 amRNSExecution of Loan Agreement to Globalworth Poland
12th Apr 20188:00 amRNSUpdate on Poland
4th Apr 20186:21 pmRNSDirector Shareholdings
28th Mar 20182:15 pmRNSApplication for Admission of Shares to trading
23rd Mar 20181:30 pmRNSIssuance of senior unsecured notes
22nd Mar 201810:29 amRNSPre Stab Notice - Globalworth EUR 7y due 2025
20th Mar 20186:22 pmRNSEMTN programme
16th Mar 20189:30 amRNSFixed Income Investor Meetings
15th Mar 20187:00 amRNSAcquisition in Poland
8th Mar 20187:00 amRNSAudited Results for the year to 31 December 2017
28th Feb 20189:15 amRNSUpdate on Poland
28th Feb 20187:00 amRNSBusiness Update
26th Jan 20187:00 amRNSDirector/PDMR Shareholding
3rd Jan 201811:05 amRNSExercise of Warrants and Total Voting Rights
3rd Jan 201811:00 amRNSInterim Dividend Payment
22nd Dec 20171:30 pmRNSBusiness Update, Shareholdings & Voting Rights
19th Dec 20174:41 pmRNSDirector/PDMR Shareholding
19th Dec 20177:00 amRNSFurther update on Investment in Poland
15th Dec 20172:30 pmRNSDirector/PDMR Shareholding
14th Dec 20176:15 pmRNSSignificant Shareholding
13th Dec 20176:33 pmRNSSignificant Shareholdings and Director's Dealing
13th Dec 20177:00 amRNSAppointment of Non-Executive Director
12th Dec 20179:30 amRNSTotal Voting Rights
8th Dec 20177:00 amRNSResults of Placing
4th Dec 201710:36 amRNSResult of EGM
29th Nov 20177:00 amRNSUpdate on Investment in Poland-Offer Unconditional
27th Nov 201711:30 amRNSProposed Placing
16th Nov 20179:23 amRNSFurther update on investment in Poland
14th Nov 20177:00 amRNSIntention to raise additional equity capital
9th Nov 20172:40 pmRNSFurther update on Investment in Poland
25th Oct 201712:30 pmRNSUpdate on Investment in Poland
17th Oct 20172:21 pmRNSDirector/PDMR Shareholding
16th Oct 20177:00 amRNSDirector/PDMR Shareholding
11th Oct 201712:43 pmRNSDirector/PDMR Shareholding
5th Oct 20176:19 pmRNSDirector/PDMR Shareholding
4th Oct 20177:00 amRNSStrategic Investment in Poland
20th Sep 20173:00 pmRNSHalf-year Report
31st Aug 201710:34 amRNSEGM results
30th Aug 20177:00 amRNSUpdate and EPRA Net Asset Value at 30 June 2017
11th Aug 20177:00 amRNSSatisfaction of employee share awards
9th Aug 20177:00 amRNSCompleted acquisition of Green Court Bucharest
1st Aug 20177:00 amRNSNotice of EGM
24th Jul 20177:00 amRNSAppointment of Joint Broker
12th Jul 20177:00 amRNSDevelopment of Groupe Renault Romania's new HQ
7th Jul 201710:55 amRNSPurchase of own shares for employee award plan
30th Jun 20177:30 amRNSAcquisition of Green Court Building "C"

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.